Navigation Links
Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
Date:9/9/2011

Nektar using its polymer conjugate technology platform.  NKTR-102 has been evaluated in two separate Phase 2 studies for the treatment of platinum-refractory/resistant ovarian cancer and metastatic breast cancer patients.  In addition, NKTR-102 is also being tested as a single agent in a Phase 2 clinical trial in patients with second-line colorectal cancer and a Phase 1 clinical trial evaluating NKTR-102 in combination with 5-FU therapy.  

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation.  The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid.  NKTR-181, a novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies.  In oncology, NKTR-102, a novel topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... Aug. 29, 2014  A Boston Scientific Corporation ... on stent removability and preliminary long term stricture ... in the August issue of the peer-reviewed journal, ... is being conducted in 11 countries and ... self-expanding metal stents (FCSEMS) after extended indwell (i.e., ...
(Date:8/29/2014)... Aug. 29, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... 2014 Morgan Stanley Global Healthcare Conference on Wednesday, September ... and Chief Executive Officer, will provide an update on ... (9:55 a.m., Pacific Daylight Time).   A ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... May 20 The owner and operator of a Houston-area ... program, announced the Departments of Justice and Health and Human Services (HHS). ... William M. ... fraud before U.S. District Judge David Hittner in U.S. District ...
... May 20 Inverness Medical Innovations, Inc. (NYSE: ... charge of their health at home through the merger of rapid ... Citi Global Health Care Conference being held May 26 through ... New York City .  Jon Russell, Vice President, Finance, will attend. ...
Cached Medicine Technology:Houston-Area Durable Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutrition Supplies 2Houston-Area Durable Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutrition Supplies 3
(Date:9/1/2014)... Top10BestSEOHosting.com is a leading review website in the world. ... and announced that GreenGeeks, Arvixe and Hostgator are the ... ( http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ) is one of the best web ... lot of useful products for sale. On its website, ... , As one of the Top 10 Web ...
(Date:9/1/2014)... Phoenix, AZ (PRWEB) September 01, 2014 ... Wellness conference, the American Sleep and Breathing Academy ... Wellness conference: A Conference for Healthcare Professionals. The event ... Scottsdale, Arizona on April 10th and 11th. This years’ ... experience delivered by the ASBA. , In recent ...
(Date:9/1/2014)... may be bad for your waistline. TV viewers ate ... excerpt from a Hollywood action film than those watching ... for helping Americans to gain weight because it encourages ... been on the medium and not the message. TV ... to eat more, including reading, listening to the radio ...
(Date:9/1/2014)... (PRWEB) September 02, 2014 Renal cell carcinoma ... the lining of the proximal convoluted tubule, a part of ... molecules from the blood to the urine. The condition is ... with RCC are often in the advanced stages of the ... of RCC often include blood in the urine, flank pain, ...
(Date:9/1/2014)... -- You may be able to convince your brain that ... The study included eight overweight and obese people who ... change how people react to different foods. These participants were ... people who weren,t in the program. Both groups had ... again six months later. The scans revealed that the people ...
Breaking Medicine News(10 mins):Health News:The Best Reseller Hosting Suppliers in August Released by Leading Review SiteTop10BestSEOHosting.com 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Research letter: Viewers ate more while watching Hollywood action flick on TV 2Health News:Renal Cell Carcinoma Market Analysis & Epidemiology Forecast to 2023 Says a New Report Available at MarketOptimizer.org 2Health News:Renal Cell Carcinoma Market Analysis & Epidemiology Forecast to 2023 Says a New Report Available at MarketOptimizer.org 3Health News:Renal Cell Carcinoma Market Analysis & Epidemiology Forecast to 2023 Says a New Report Available at MarketOptimizer.org 4Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2
... News) -- Very few young women with cancer take ... a new study says. The findings suggest that ... preservation methods such as egg or embryo freezing, said ... Francisco, and colleagues. The researchers surveyed 1,041 women ...
... -- Women should be screened for heart disease -- ... United States -- during routine visits to obstetrics and ... from Mount Sinai Medical Center in New York City ... could help identify women with undetected risk factors for ...
... HealthDay Reporter , MONDAY, March 26 (HealthDay News) -- Although ... more than 50 percent following the start of a U.S. ... backs, new research suggests that risk factors other than "tummy ... Chief among those other risk factors are bed-sharing (where ...
... for cancer trials are not up to the job, reveals ... published in the international journal Sociology of Health and ... long and incomprehensible, and even intimidating. ... and how they really make decisions about whether to join ...
... (ACP), representing 132,000 internal medicine specialists and medical student members, ... has resulted in major improvements in access and coverage for ... Considering that it is just a little over two years ... its programs are not yet fully effective, the ACA has ...
... from the insidious and often devastating problem of chronic ... is striking given the many breakthroughs in understanding the ... A major challenge for treating chronic pain is ... with apparently similar disorders or injuries, do not. An ...
Cached Medicine News:Health News:Few Young Women With Cancer Take Steps to Preserve Fertility 2Health News:Ob/Gyn Visit a Good Time to Screen for Heart Disease: Study 2Health News:Bed-Sharing, Smoking Play Role in Sudden Infant Death 2Health News:Bed-Sharing, Smoking Play Role in Sudden Infant Death 3Health News:Cancer trial information leaflets 'not fit for purpose'- new study 2Health News:The present and future of the Affordable Care Act 2Health News:The present and future of the Affordable Care Act 3Health News:The present and future of the Affordable Care Act 4Health News:Study suggests new way to treat chronic pain 2
Toxoplasma IgG II ELISA...
ELISA kit for CMV CAP M....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of small sized foreign bodies....
Blunt tipped forceps with a thin tip angled at approximately 135 and hollowed out "notch" on the interior of the distal end. Tip is shaped like a pic when in the closed position. For membrane peeling...
Medicine Products: